category,subcategory,ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
Environmental Information Processing,Signaling molecules and interaction,hsa04060,Cytokine-cytokine receptor interaction,28/278,127/2914,0.2204724409448819,2.310995298249589,4.905174338448593,1.271775199779033e-5,0.002511463830346278,0.002361406336081348,TNFRSF1B/NGFR/IL4R/CXCL2/CSF2RB/IL7/CSF3/CCL2/CCL8/IL1R1/IL1RL1/IL18RAP/TNFRSF10B/TNFSF10/IL1B/LIF/IL15RA/IL6/OSMR/IFNA5/INHBB/CCR1/IL7R/TNFRSF10D/TNFRSF10C/CXCR2/RELL1/CCR10,28
Environmental Information Processing,Signaling molecules and interaction,hsa04061,Viral protein interaction with cytokine and cytokine receptor,13/278,37/2914,0.35135135135135137,3.6828699202799924,5.332740917276056,1.7875187404599845e-5,0.002511463830346278,0.002361406336081348,TNFRSF1B/CXCL2/CCL2/CCL8/IL18RAP/TNFRSF10B/TNFSF10/IL6/CCR1/TNFRSF10D/TNFRSF10C/CXCR2/CCR10,13
Environmental Information Processing,Signal transduction,hsa04630,JAK-STAT signaling pathway,15/278,59/2914,0.2542372881355932,2.664918912327765,4.195038717697452,2.8087848842980764e-4,0.026308951749591983,0.024737017752940956,IL4R/CSF2RB/IL7/JAK3/CSF3/CISH/CDKN1A/LIF/IL15RA/IL6/PIM1/OSMR/IFNA5/IL7R/SOCS3,15
Organismal Systems,Immune system,hsa04640,Hematopoietic cell lineage,13/278,49/2914,0.2653061224489796,2.780942592864484,4.082306277025913,4.586076617342857e-4,0.02871822321374893,0.027002337616223945,IL4R/IL7/CSF3/IL1R1/CR2/IL1B/IL6/FCGR1A/IL7R/CD14/CR1/CD8B2/ITGB3,13
Human Diseases,Infectious disease: parasitic,hsa05144,Malaria,10/278,32/2914,0.3125,3.275629496402878,4.202904216632083,5.110004130560307e-4,0.02871822321374893,0.027002337616223945,SELE/CSF3/CCL2/IL1B/IL6/TLR2/THBS1/CR1/ACKR1/PECAM1,10
Organismal Systems,Immune system,hsa04610,Complement and coagulation cascades,11/278,40/2914,0.275,2.8825539568345326,3.8927273252729004,9.071684851393328e-4,0.04248572405402542,0.03994724381929343,TFPI/PLAUR/CR2/F3/F13A1/C1R/BDKRB2/THBD/SERPINA1/C5AR1/CR1,11
Environmental Information Processing,Signaling molecules and interaction,hsa04080,Neuroactive ligand-receptor interaction,30/278,198/2914,0.15151515151515152,1.5881839982559407,2.783561716587911,0.005905438285176084,0.23706116544778283,0.2228969939216838,EDN1/NTSR1/CHRNA4/CALCA/POMC/PRLHR/HCRTR1/EDN3/MCHR1/VGF/CHRNA10/HCRTR2/ADCYAP1/GABRA6/CHRNA6/ADM/LYPD6B/ADRA2A/GRM2/BDKRB2/DRD5/TRH/FPR2/FPR1/P2RY6/HTR1A/QRFPR/LYPD6/C5AR1/SSTR3,30
Human Diseases,Infectious disease: bacterial,hsa05152,Tuberculosis,15/278,80/2914,0.1875,1.9653776978417266,2.842904489782402,0.00736523727526334,0.25870395929362483,0.2432466521172498,BAD/SPHK2/CD209/CTSD/IL1B/IL6/TLR2/FCGR2A/IFNA5/FCGR1A/FCER1G/CD14/CARD9/CR1/FCGR3A,15
Human Diseases,Immune disease,hsa05340,Primary immunodeficiency,5/278,15/2914,0.3333333333333333,3.494004796163069,3.1444069208422882,0.010261049565925945,0.2886275576024019,0.27138234485185564,BLNK/JAK3/RAG1/IL7R/CD8B2,5
Human Diseases,Cancer: specific types,hsa05220,Chronic myeloid leukemia,7/278,27/2914,0.25925925925925924,2.7175592859046094,2.9113214770387574,0.01110489354784539,0.2886275576024019,0.27138234485185564,BAD/GADD45B/GADD45A/CDKN1A/RUNX1/SHC1/CRK,7
Environmental Information Processing,Signal transduction,hsa04064,NF-kappa B signaling pathway,10/278,47/2914,0.2127659574468085,2.2302158273381294,2.76080879591589,0.011298587664150962,0.2886275576024019,0.27138234485185564,CXCL2/BLNK/GADD45B/IL1R1/GADD45A/IL1B/BCL2A1/LY96/CD14/CARD11,10
Environmental Information Processing,Signal transduction,hsa04068,FoxO signaling pathway,11/278,55/2914,0.2,2.096402877697842,2.6654121380654123,0.012852653529274895,0.30096630347718717,0.2829838627936841,GADD45B/BCL6/GADD45A/TNFSF10/CDK2/CDKN1A/IL6/PLK4/DEPP1/RAG1/IL7R,11
Environmental Information Processing,Signal transduction,hsa04668,TNF signaling pathway,12/278,63/2914,0.19047619047619047,1.9965741692360397,2.5965771421018577,0.014032472399250347,0.3033172880145652,0.285194378316748,SELE/TNFRSF1B/BCL3/EDN1/CXCL2/CCL2/IRF1/IL1B/LIF/IL6/CREB3L1/SOCS3,12
Human Diseases,Infectious disease: viral,hsa05168,Herpes simplex virus 1 infection,10/278,49/2914,0.20408163265306123,2.139186609895757,2.6112625229549926,0.015120263799329984,0.303485294829409,0.28535234688961103,BAD/CCL2/IL1B/IL6/TLR2/IFNA5/B2M/SOCS3/CARD9/ITGB3,10
Cellular Processes,Transport and catabolism,hsa04145,Phagosome,12/278,66/2914,0.18181818181818182,1.905820797907129,2.416930713415215,0.019991260588141085,0.3400899120042278,0.3197698741826603,MSR1/CD209/TLR2/THBS1/FCGR2A/FCGR1A/C1R/CD14/TUBB6/SFTPA2/FCGR3A/ITGB3,12
Organismal Systems,Immune system,hsa04666,Fc gamma R-mediated phagocytosis,9/278,44/2914,0.20454545454545456,2.1440483976455202,2.4828456646627757,0.020454433107136166,0.3400899120042278,0.3197698741826603,SPHK2/HCK/LIMK1/RAC2/FCGR2A/FCGR1A/CRK/LIMK2/FCGR3A,9
Human Diseases,Cancer: specific types,hsa05217,Basal cell carcinoma,8/278,37/2914,0.21621621621621623,2.2663814894030723,2.5171866643150422,0.0205748345340636,0.3400899120042278,0.3197698741826603,WNT8A/GADD45B/APC2/GADD45A/CDKN1A/WNT9A/WNT7A/FZD8,8
Organismal Systems,Immune system,hsa04621,NOD-like receptor signaling pathway,13/278,78/2914,0.16666666666666666,1.7470023980815346,2.1713814403542244,0.030859101043699436,0.43706557773140087,0.4109513392417367,CXCL2/NLRP1/NAMPT/NOD1/CCL2/GBP1/IL1B/IL6/IFNA5/GBP2/IFI16/CARD9/CASP4,13
Metabolism,Global and overview maps,hsa01210,2-Oxocarboxylic acid metabolism,3/278,8/2914,0.375,3.930755395683453,2.695235380676403,0.033469433757943715,0.43706557773140087,0.4109513392417367,GPT/ACY1/BCKDHA,3
Human Diseases,Infectious disease: viral,hsa05169,Epstein-Barr virus infection,12/278,71/2914,0.16901408450704225,1.7716080656601478,2.1372604072403463,0.0338434618969455,0.43706557773140087,0.4109513392417367,BLNK/GADD45B/JAK3/GADD45A/CR2/CDK2/CDKN1A/IL6/TLR2/IFNA5/B2M/ISG15,12
Human Diseases,Infectious disease: bacterial,hsa05134,Legionellosis,6/278,27/2914,0.2222222222222222,2.3293365307753797,2.2532706870844494,0.03792153777538157,0.43706557773140087,0.4109513392417367,CXCL2/IL1B/IL6/TLR2/CD14/CR1,6
Human Diseases,Cancer: specific types,hsa05221,Acute myeloid leukemia,6/278,27/2914,0.2222222222222222,2.3293365307753797,2.2532706870844494,0.03792153777538157,0.43706557773140087,0.4109513392417367,BAD/PIM1/BCL2A1/FCGR1A/RUNX1/CD14,6
Human Diseases,Infectious disease: bacterial,hsa05133,Pertussis,8/278,42/2914,0.19047619047619047,1.9965741692360397,2.1123310890633324,0.04152653220343256,0.43706557773140087,0.4109513392417367,NOD1/IRF1/IL1B/IL6/LY96/C1R/CD14/SFTPA2,8
Organismal Systems,Immune system,hsa04659,Th17 cell differentiation,7/278,35/2914,0.2,2.096402877697842,2.1188650320256053,0.04358188719167894,0.43706557773140087,0.4109513392417367,IL4R/JAK3/IL1R1/IL1B/IL6/IRF4/RUNX1,7
Human Diseases,Infectious disease: bacterial,hsa05150,Staphylococcus aureus infection,7/278,35/2914,0.2,2.096402877697842,2.1188650320256053,0.04358188719167894,0.43706557773140087,0.4109513392417367,FCGR2A/FCGR1A/C1R/FPR2/FPR1/C5AR1/FCGR3A,7
Organismal Systems,Immune system,hsa04062,Chemokine signaling pathway,13/278,82/2914,0.15853658536585366,1.6617827689068259,1.9737661386502223,0.044255384349963824,0.43706557773140087,0.4109513392417367,BAD/CXCL2/HCK/JAK3/CCL2/CCL8/RAC2/SHC1/CCR1/CRK/RAC3/CXCR2/CCR10,13
Human Diseases,Cancer: specific types,hsa05224,Breast cancer,12/278,74/2914,0.16216216216216217,1.6997861170523043,1.9798940453842593,0.0448783022892489,0.43706557773140087,0.4109513392417367,WNT8A/GADD45B/APC2/GADD45A/CDKN1A/FGF2/WNT9A/NOTCH1/WNT7A/SHC1/FZD8/JAG2,12
Human Diseases,Cancer: specific types,hsa05226,Gastric cancer,11/278,66/2914,0.16666666666666666,1.7470023980815346,1.9931680119175055,0.04510641193669261,0.43706557773140087,0.4109513392417367,WNT8A/GADD45B/APC2/GADD45A/CDK2/CDKN1A/FGF2/WNT9A/WNT7A/SHC1/FZD8,11
Human Diseases,Cardiovascular disease,hsa05418,Fluid shear stress and atherosclerosis,11/278,66/2914,0.16666666666666666,1.7470023980815346,1.9931680119175055,0.04510641193669261,0.43706557773140087,0.4109513392417367,SELE/EDN1/CCL2/IL1R1/IL1B/RAC2/RAC3/THBD/CDH5/ITGB3/PECAM1,11
Human Diseases,Cancer: overview,hsa05202,Transcriptional misregulation in cancer,12/278,75/2914,0.16,1.6771223021582735,1.9290122739774402,0.04905459010440748,0.4594779939779501,0.4320246356563607,NGFR/GADD45B/LYL1/BCL6/GADD45A/CDKN1A/IL6/BCL2A1/FCGR1A/RUNX1/CD14/H3C2,12
Human Diseases,Endocrine and metabolic disease,hsa04933,AGE-RAGE signaling pathway in diabetic complications,9/278,52/2914,0.17307692307692307,1.8141947980077475,1.9236015471660286,0.05430367217709042,0.4922365123149164,0.462825864735134,SELE/EDN1/CCL2/F3/IL1B/IL6/PIM1/THBD/COL4A1,9
Organismal Systems,Immune system,hsa04657,IL-17 signaling pathway,7/278,37/2914,0.1891891891891892,1.983083803227688,1.9540758137228396,0.05670601450260214,0.49794968985097504,0.4681976855313532,CXCL2/CSF3/CCL2/IL1B/IL6/S100A8/S100A9,7
Genetic Information Processing,Translation,hsa03008,Ribosome biogenesis in eukaryotes,3/278,10/2914,0.3,3.1446043165467623,2.2058135849065743,0.0621781354691038,0.5005030275877596,0.470598463849139,FBLL1/RNA5S9/SNORD3B-1,3
Human Diseases,Infectious disease: viral,hsa05163,Human cytomegalovirus infection,14/278,95/2914,0.14736842105263157,1.54471790988262,1.7526930186525713,0.06373139658370221,0.5005030275877596,0.470598463849139,CCL2/IL1R1/CDKN1A/IL1B/RAC2/IL6/IFNA5/CREB3L1/CCR1/B2M/CRK/RAC3/CXCR2/ITGB3,14
Human Diseases,Cancer: specific types,hsa05210,Colorectal cancer,7/278,38/2914,0.18421052631578946,1.9308973873532753,1.8755087998134137,0.06409616088028135,0.5005030275877596,0.470598463849139,BAD/GADD45B/APC2/GADD45A/CDKN1A/RAC2/RAC3,7
Human Diseases,Endocrine and metabolic disease,hsa04934,Cushing syndrome,11/278,70/2914,0.15714285714285714,1.6471736896197329,1.7796107246776305,0.06476107309771359,0.5005030275877596,0.470598463849139,CACNA1G/WNT8A/POMC/APC2/CDK2/CDKN1A/ARMC5/WNT9A/WNT7A/CREB3L1/FZD8,11
Cellular Processes,Cell growth and death,hsa04115,p53 signaling pathway,6/278,31/2914,0.1935483870967742,2.028776978417266,1.8698195671692421,0.06853331756163333,0.5005030275877596,0.470598463849139,GADD45B/GADD45A/TNFRSF10B/CDK2/CDKN1A/THBS1,6
Human Diseases,Cancer: specific types,hsa05212,Pancreatic cancer,6/278,31/2914,0.1935483870967742,2.028776978417266,1.8698195671692421,0.06853331756163333,0.5005030275877596,0.470598463849139,BAD/GADD45B/GADD45A/CDKN1A/RAC2/RAC3,6
Cellular Processes,Transport and catabolism,hsa04148,Efferocytosis,11/278,71/2914,0.15492957746478872,1.6239740601884687,1.7283321848701316,0.07042930181785431,0.5005030275877596,0.470598463849139,SPHK2/ATP2A3/DUSP4/THBS1/CH25H/DUSP5/DUSP2/CRK/P2RY6/ITGB3/PECAM1,11
Organismal Systems,Immune system,hsa04613,Neutrophil extracellular trap formation,13/278,88/2914,0.14772727272727273,1.5484793982995422,1.696428320729192,0.07124598257477004,0.5005030275877596,0.470598463849139,RAC2/SIGLEC9/TLR2/FCGR2A/FCGR1A/FPR2/FPR1/CASP4/C5AR1/CR1/FCGR3A/ITGB3/H3C2,13
Cellular Processes,Cell growth and death,hsa04210,Apoptosis,9/278,55/2914,0.16363636363636364,1.715238718116416,1.7387823396494482,0.07314259089632387,0.5012943424845612,0.4713424984589806,BAD/GADD45B/CSF2RB/LMNB1/GADD45A/CTSD/TNFRSF10B/TNFSF10/BCL2A1,9
Organismal Systems,Endocrine system,hsa04910,Insulin signaling pathway,9/278,56/2914,0.16071428571428573,1.6846094552929087,1.6796768304227243,0.08022082949939946,0.5293044287247765,0.497679009589507,BAD/PYGL/TRIP10/HK2/SHC1/SH2B2/CRK/PPP1R3B/SOCS3,9
Human Diseases,Infectious disease: parasitic,hsa05146,Amoebiasis,8/278,48/2914,0.16666666666666666,1.7470023980815346,1.694433226387106,0.0810451393506287,0.5293044287247765,0.497679009589507,CXCL2/IL1R1/IL1B/IL6/TLR2/GNA14/CD14/COL4A1,8
Human Diseases,Immune disease,hsa05321,Inflammatory bowel disease,5/278,25/2914,0.2,2.096402877697842,1.7876658237891743,0.08288040876829239,0.5293044287247765,0.497679009589507,IL4R/IL18RAP/IL1B/IL6/TLR2,5
Cellular Processes,Cellular community - eukaryotes,hsa04550,Signaling pathways regulating pluripotency of stem cells,10/278,65/2914,0.15384615384615385,1.612617598229109,1.6218842608629378,0.0854187288711526,0.5333925069509751,0.501522829161621,WNT8A/JAK3/APC2/LIF/FGF2/WNT9A/WNT7A/ZIC3/INHBB/FZD8,10
Human Diseases,Cancer: specific types,hsa05225,Hepatocellular carcinoma,10/278,66/2914,0.15151515151515152,1.5881839982559407,1.5694053104197956,0.09261735689516318,0.5657712453813228,0.5319669698097473,BAD/WNT8A/GADD45B/APC2/GADD45A/CDKN1A/WNT9A/WNT7A/SHC1/FZD8,10
Human Diseases,Cardiovascular disease,hsa05417,Lipid and atherosclerosis,13/278,93/2914,0.13978494623655913,1.4652278177458034,1.4805584028713943,0.10060466446451924,0.6014874620112747,0.5655491776168943,BAD/SELE/CXCL2/CCL2/TNFRSF10B/TNFSF10/IL1B/IL6/TLR2/IFNA5/LY96/CD14/MIB2,13
Genetic Information Processing,Information processing in viruses,hsa03265,"Virion - Ebolavirus, Lyssavirus and Morbillivirus",2/278,6/2914,0.3333333333333333,3.494004796163069,1.9856177467160068,0.10515942771402723,0.6156208164092011,0.578838077987299,NGFR/CD209,2
Human Diseases,Cancer: specific types,hsa05213,Endometrial cancer,5/278,27/2914,0.18518518518518517,1.9411137756461494,1.5952198971301415,0.10797700696120306,0.6192150807366951,0.582217588555574,BAD/GADD45B/APC2/GADD45A/CDKN1A,5
Human Diseases,Infectious disease: viral,hsa05165,Human papillomavirus infection,19/278,149/2914,0.12751677852348994,1.3366327072570132,1.3696885128036314,0.11250658511443949,0.63228700834315,0.5945084813415644,BAD/WNT8A/COL9A3/APC2/CDK2/CDKN1A/IRF1/THBS1/WNT9A/IFNA5/NOTCH1/WNT7A/CREB3L1/FZD8/SCRIB/COL4A1/ISG15/HES4/ITGB3,19
Human Diseases,Infectious disease: viral,hsa05162,Measles,8/278,52/2914,0.15384615384615385,1.612617598229109,1.4473589890996048,0.11667181616932373,0.6428388302662739,0.6044298422807071,BAD/CD209/JAK3/CDK2/IL1B/IL6/TLR2/IFNA5,8
Environmental Information Processing,Signal transduction,hsa04151,PI3K-Akt signaling pathway,21/278,171/2914,0.12280701754385964,1.2872649249021835,1.2571517101607117,0.13192721783653713,0.7129143886935949,0.6703184549994095,BAD/NGFR/IL4R/ANGPT2/COL9A3/IL7/JAK3/CSF3/CDK2/CDKN1A/IL6/TLR2/THBS1/FGF2/OSMR/IFNA5/CREB3L1/IL7R/EFNA1/COL4A1/ITGB3,21
Human Diseases,Cancer: overview,hsa05200,Pathways in cancer,29/278,249/2914,0.11646586345381527,1.220796856490711,1.182943194722934,0.14276434498988658,0.7368673396391584,0.6928402406796358,BAD/WNT8A/IL4R/EDN1/GADD45B/CSF2RB/IL7/JAK3/APC2/GADD45A/CDK2/CDKN1A/RAC2/IL15RA/IL6/PIM1/FGF2/WNT9A/IFNA5/NOTCH1/WNT7A/RUNX1/CRK/BDKRB2/IL7R/RAC3/FZD8/JAG2/COL4A1,29
Organismal Systems,Immune system,hsa04625,C-type lectin receptor signaling pathway,7/278,46/2914,0.15217391304347827,1.595089146074445,1.3209649940093267,0.14303164307134306,0.7368673396391584,0.6928402406796358,BCL3/CD209/IRF1/IL1B/IL6/FCER1G/CARD9,7
Human Diseases,Cancer: overview,hsa05206,MicroRNAs in cancer,11/278,81/2914,0.13580246913580246,1.423483435473843,1.255092074310244,0.1442267034880915,0.7368673396391584,0.6928402406796358,APC2/CDKN1A/PIM1/THBS1/CYP1B1/NOTCH1/SHC1/CRK/EFNA1/MIR9-1/ITGB3,11
Organismal Systems,Immune system,hsa04650,Natural killer cell mediated cytotoxicity,8/278,56/2914,0.14285714285714285,1.4974306269270299,1.2204369839363463,0.15940534690899186,0.7847695876706055,0.7378803764949315,TNFRSF10B/TNFSF10/RAC2/IFNA5/FCER1G/SHC1/RAC3/FCGR3A,8
Organismal Systems,Development and regeneration,hsa04380,Osteoclast differentiation,9/278,65/2914,0.13846153846153847,1.4513558384061982,1.1949492350133804,0.16165996024812834,0.7847695876706055,0.7378803764949315,ATP2A3/BLNK/IL1R1/IL1B/FCGR2A/FCGR1A/SOCS3/FCGR3A/ITGB3,9
Human Diseases,Cancer: specific types,hsa05216,Thyroid cancer,3/278,15/2914,0.2,2.096402877697842,1.3823296578933597,0.16618819752607777,0.7847695876706055,0.7378803764949315,GADD45B/GADD45A/CDKN1A,3
Human Diseases,Cancer: specific types,hsa05218,Melanoma,5/278,31/2914,0.16129032258064516,1.6906474820143884,1.2552634856520786,0.16760954072092346,0.7847695876706055,0.7378803764949315,BAD/GADD45B/GADD45A/CDKN1A/FGF2,5
Human Diseases,Infectious disease: viral,hsa05171,Coronavirus disease - COVID-19,11/278,84/2914,0.13095238095238096,1.3726447413497775,1.1252819678755814,0.1722315752906465,0.7847695876706055,0.7378803764949315,CSF3/CCL2/F13A1/IL1B/IL6/TLR2/FCGR2A/IFNA5/C1R/ISG15/C5AR1,11
Human Diseases,Infectious disease: bacterial,hsa05135,Yersinia infection,9/278,66/2914,0.13636363636363635,1.4293655984303464,1.1456426089220857,0.17256142393543847,0.7847695876706055,0.7378803764949315,LIMK1/CCL2/IL1B/RAC2/IL6/FCGR2A/CRK/RAC3/CD8B2,9
Metabolism,Metabolism of cofactors and vitamins,hsa00770,Pantothenate and CoA biosynthesis,2/278,8/2914,0.25,2.620503597122302,1.4902774335620983,0.17315200866753572,0.7847695876706055,0.7378803764949315,VNN2/GADL1,2
Environmental Information Processing,Signal transduction,hsa04066,HIF-1 signaling pathway,7/278,49/2914,0.14285714285714285,1.4974306269270299,1.140218768884072,0.18100829563083323,0.8073544614645102,0.7591158262880392,EDN1/ANGPT2/TIMP1/CDKN1A/IL6/PDK1/HK2,7
Human Diseases,Infectious disease: parasitic,hsa05140,Leishmaniasis,6/278,41/2914,0.14634146341463414,1.5339533251447621,1.1180142732677596,0.19121716506279338,0.8358638912051762,0.7859218456358841,IL1B/TLR2/FCGR2A/FCGR1A/CR1/FCGR3A,6
NA,NA,hsa04081,Hormone signaling,14/278,114/2914,0.12280701754385964,1.2872649249021835,1.0159584553436043,0.19334929867735395,0.8358638912051762,0.7859218456358841,HAMP/CALCA/POMC/PRLHR/HCRTR1/MCHR1/RAMP2/HCRTR2/ADRA2A/GNA14/DRD5/TRH/ITGB3/SSTR3,14
Human Diseases,Cancer: specific types,hsa05223,Non-small cell lung cancer,5/278,33/2914,0.15151515151515152,1.5881839982559407,1.1033631702472018,0.20140437896903976,0.8574944013681844,0.8062599540865867,BAD/GADD45B/JAK3/GADD45A/CDKN1A,5
Organismal Systems,Digestive system,hsa04978,Mineral absorption,4/278,25/2914,0.16,1.6771223021582735,1.1040361373690097,0.21070667214385508,0.8837100727227355,0.830909264856365,MT2A/MT1X/MT1A/MT1M,4
Human Diseases,Infectious disease: bacterial,hsa05130,Pathogenic Escherichia coli infection,10/278,80/2914,0.125,1.310251798561151,0.9136488579179587,0.2281026704685099,0.9262480672887687,0.870905656075973,IL1R1/TNFRSF10B/TNFSF10/IL1B/IL6/MYO1G/FCGR2A/MYO5B/TUBB6/CASP4,10
Human Diseases,Infectious disease: viral,hsa05170,Human immunodeficiency virus 1 infection,10/278,80/2914,0.125,1.310251798561151,0.9136488579179587,0.2281026704685099,0.9262480672887687,0.870905656075973,BAD/TNFRSF1B/LIMK1/RAC2/TLR2/IFNA5/B2M/CRK/RAC3/LIMK2,10
Human Diseases,Substance dependence,hsa05033,Nicotine addiction,4/278,26/2914,0.15384615384615385,1.612617598229109,1.0188200547776618,0.23174356309241206,0.9262480672887687,0.870905656075973,SLC17A6/CHRNA4/GABRA6/CHRNA6,4
Organismal Systems,Immune system,hsa04662,B cell receptor signaling pathway,5/278,35/2914,0.14285714285714285,1.4974306269270299,0.9613148439261275,0.23726703642852398,0.9262480672887687,0.870905656075973,BLNK/CR2/RAC2/RAC3/CARD11,5
Organismal Systems,Endocrine system,hsa04916,Melanogenesis,7/278,53/2914,0.1320754716981132,1.384416994706122,0.917067963792199,0.23733046563982688,0.9262480672887687,0.870905656075973,WNT8A/EDN1/POMC/WNT9A/WNT7A/CREB3L1/FZD8,7
Metabolism,Glycan biosynthesis and metabolism,hsa00532,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,2/278,10/2914,0.2,2.096402877697842,1.1276953718207376,0.24604408231718627,0.9336011889392221,0.8778194359383582,CHST3/CHSY1,2
Human Diseases,Immune disease,hsa05332,Graft-versus-host disease,2/278,10/2914,0.2,2.096402877697842,1.1276953718207376,0.24604408231718627,0.9336011889392221,0.8778194359383582,IL1B/IL6,2
Organismal Systems,Immune system,hsa04623,Cytosolic DNA-sensing pathway,4/278,27/2914,0.14814814814814814,1.5528910205169197,0.9371691071758333,0.25326818155001385,0.9336011889392221,0.8778194359383582,IL1B/IL6/IFNA5/IFI16,4
Organismal Systems,Immune system,hsa04620,Toll-like receptor signaling pathway,6/278,45/2914,0.13333333333333333,1.3976019184652277,0.8727892557008656,0.25491818897467344,0.9336011889392221,0.8778194359383582,IL1B/IL6/TLR2/IFNA5/LY96/CD14,6
Human Diseases,Cancer: specific types,hsa05222,Small cell lung cancer,5/278,36/2914,0.1388888888888889,1.4558353317346124,0.893580693929591,0.2558266603143064,0.9336011889392221,0.8778194359383582,GADD45B/GADD45A/CDK2/CDKN1A/COL4A1,5
Human Diseases,Infectious disease: viral,hsa05161,Hepatitis B,8/278,64/2914,0.125,1.310251798561151,0.81489527965581,0.26253297406997295,0.9457918681238769,0.8892817340291932,BAD/JAK3/CDK2/CDKN1A/IL6/TLR2/IFNA5/CREB3L1,8
Human Diseases,Infectious disease: parasitic,hsa05143,African trypanosomiasis,3/278,19/2914,0.15789473684210525,1.6550549034456643,0.9301439287506331,0.26966974406911315,0.9592050390306429,0.9018934811638563,SELE/IL1B/IL6,3
Human Diseases,Infectious disease: viral,hsa05164,Influenza A,7/278,56/2914,0.125,1.310251798561151,0.7611971374499679,0.2828661683901423,0.9818343943235283,0.9231707547301204,CCL2/TNFRSF10B/TNFSF10/IL1B/IL6/IFNA5/SOCS3,7
Human Diseases,Drug resistance: antineoplastic,hsa01523,Antifolate resistance,2/278,11/2914,0.18181818181818182,1.905820797907129,0.9773160925794919,0.28301987879076795,0.9818343943235283,0.9231707547301204,IL1B/IL6,2
Human Diseases,Endocrine and metabolic disease,hsa04930,Type II diabetes mellitus,3/278,20/2914,0.15,1.5723021582733812,0.8338943964088114,0.2967490522833924,0.9999072451192372,0.9401637704623658,CACNA1G/HK2/SOCS3,3
Organismal Systems,Endocrine system,hsa04920,Adipocytokine signaling pathway,4/278,29/2914,0.13793103448275862,1.445795088067477,0.7833959219849167,0.2974016481498311,0.9999072451192372,0.9401637704623658,TNFRSF1B/POMC/SOCS3/ACSL5,4
Human Diseases,Endocrine and metabolic disease,hsa04931,Insulin resistance,5/278,39/2914,0.1282051282051282,1.3438479985242573,0.7019397182713168,0.31330542586242754,0.9999072451192372,0.9401637704623658,PYGL/IL6/CREB3L1/PPP1R3B/SOCS3,5
Cellular Processes,Cell growth and death,hsa04217,Necroptosis,7/278,58/2914,0.1206896551724138,1.2650707020590426,0.6620892871435952,0.31433931317225244,0.9999072451192372,0.9401637704623658,PYGL/JAK3/TNFRSF10B/TNFSF10/IL1B/IFNA5/SPATA2L,7
Environmental Information Processing,Signal transduction,hsa04370,VEGF signaling pathway,4/278,30/2914,0.13333333333333333,1.3976019184652277,0.7107737952392843,0.31982813175326835,0.9999072451192372,0.9401637704623658,BAD/SPHK2/RAC2/RAC3,4
Human Diseases,Infectious disease: parasitic,hsa05142,Chagas disease,6/278,49/2914,0.12244897959183673,1.283511965937454,0.6498708508604316,0.32345036546962436,0.9999072451192372,0.9401637704623658,CCL2/IL1B/IL6/TLR2/GNA14/BDKRB2,6
Human Diseases,Infectious disease: bacterial,hsa05132,Salmonella infection,11/278,98/2914,0.11224489795918367,1.1765526354426663,0.5772857731155941,0.3302904504131196,0.9999072451192372,0.9401637704623658,NOD1/TNFRSF10B/TNFSF10/IL1B/IL6/TLR2/LY96/CD14/TUBB6/AHNAK2/CASP4,11
Human Diseases,Infectious disease: viral,hsa05167,Kaposi sarcoma-associated herpesvirus infection,9/278,79/2914,0.11392405063291139,1.1941535379291504,0.5680705304482012,0.3385601474306408,0.9999072451192372,0.9401637704623658,CXCL2/ANGPT2/HCK/CDKN1A/ZFP36/IL6/FGF2/IFNA5/CCR1,9
Organismal Systems,Digestive system,hsa04974,Protein digestion and absorption,6/278,50/2914,0.12,1.257841726618705,0.5971337708965769,0.3410301982679104,0.9999072451192372,0.9401637704623658,COL5A3/COL9A3/SLC1A5/CPB1/COL8A2/COL4A1,6
Organismal Systems,Endocrine system,hsa04917,Prolactin signaling pathway,4/278,31/2914,0.12903225806451613,1.3525179856115108,0.640707404134915,0.3423790341284305,0.9999072451192372,0.9401637704623658,CISH/IRF1/SHC1/SOCS3,4
Human Diseases,Cancer: specific types,hsa05215,Prostate cancer,4/278,31/2914,0.12903225806451613,1.3525179856115108,0.640707404134915,0.3423790341284305,0.9999072451192372,0.9401637704623658,BAD/CDK2/CDKN1A/CREB3L1,4
Metabolism,Amino acid metabolism,hsa00220,Arginine biosynthesis,2/278,13/2914,0.15384615384615385,1.612617598229109,0.7187985914215247,0.35615993072138574,0.9999072451192372,0.9401637704623658,GPT/ACY1,2
Human Diseases,Cancer: specific types,hsa05214,Glioma,4/278,32/2914,0.125,1.310251798561151,0.5730100591733129,0.3649732370073858,0.9999072451192372,0.9401637704623658,GADD45B/GADD45A/CDKN1A/SHC1,4
Human Diseases,Cancer: overview,hsa05205,Proteoglycans in cancer,10/278,91/2914,0.10989010989010989,1.151869713020792,0.47792127809402213,0.36753537864100877,0.9999072451192372,0.9401637704623658,PLAUR/WNT8A/CDKN1A/TLR2/THBS1/FGF2/WNT9A/WNT7A/FZD8/ITGB3,10
Human Diseases,Endocrine and metabolic disease,hsa04936,Alcoholic liver disease,7/278,62/2914,0.11290322580645161,1.183453237410072,0.47409612063432743,0.37885663760024507,0.9999072451192372,0.9401637704623658,CXCL2/IL1B/IL6/IFNA5/LY96/CD14/C5AR1,7
Metabolism,Lipid metabolism,hsa00061,Fatty acid biosynthesis,1/278,5/2914,0.2,2.096402877697842,0.796715461867038,0.3944891312445,0.9999072451192372,0.9401637704623658,ACSL5,1
Environmental Information Processing,Signal transduction,hsa04310,Wnt signaling pathway,9/278,83/2914,0.10843373493975904,1.1366039698361792,0.4099702751060824,0.3949634029375607,0.9999072451192372,0.9401637704623658,WNT8A/APC2/RAC2/LGR6/WNT9A/WNT7A/SOX17/RAC3/FZD8,9
Environmental Information Processing,Signal transduction,hsa04010,MAPK signaling pathway,16/278,155/2914,0.1032258064516129,1.0820143884892086,0.34072185164846924,0.407981695212222,0.9999072451192372,0.9401637704623658,CACNA1G/NGFR/ANGPT2/GADD45B/IL1R1/GADD45A/DUSP4/IL1B/RAC2/DUSP5/FGF2/DUSP2/CRK/EFNA1/RAC3/CD14,16
Human Diseases,Infectious disease: bacterial,hsa05120,Epithelial cell signaling in Helicobacter pylori infection,4/278,34/2914,0.11764705882352941,1.2331781633516716,0.4440695854794307,0.409991527792675,0.9999072451192372,0.9401637704623658,CXCL2/NOD1/F11R/CXCR2,4
Human Diseases,Drug resistance: antineoplastic,hsa01522,Endocrine resistance,5/278,44/2914,0.11363636363636363,1.1911379986919555,0.41481300299996937,0.41169596684849863,0.9999072451192372,0.9401637704623658,BAD/CDKN1A/NOTCH1/SHC1/JAG2,5
Environmental Information Processing,Signal transduction,hsa04071,Sphingolipid signaling pathway,6/278,54/2914,0.1111111111111111,1.1646682653876899,0.396591782576019,0.4119501928951381,0.9999072451192372,0.9401637704623658,SPHK2/CTSD/RAC2/FCER1G/BDKRB2/RAC3,6
Human Diseases,Infectious disease: viral,hsa05166,Human T-cell leukemia virus 1 infection,9/278,85/2914,0.10588235294117647,1.1098603470165045,0.33377506790893946,0.4233704368685798,0.9999072451192372,0.9401637704623658,JAK3/IL1R1/CDK2/CDKN1A/ZFP36/IL15RA/IL6/CREB3L1/B2M,9
Metabolism,Carbohydrate metabolism,hsa00500,Starch and sucrose metabolism,2/278,15/2914,0.13333333333333333,1.3976019184652277,0.5012910264188954,0.42648246226107056,0.9999072451192372,0.9401637704623658,PYGL/HK2,2
Metabolism,Carbohydrate metabolism,hsa00520,Amino sugar and nucleotide sugar metabolism,2/278,15/2914,0.13333333333333333,1.3976019184652277,0.5012910264188954,0.42648246226107056,0.9999072451192372,0.9401637704623658,HK2/AMDHD2,2
Human Diseases,Immune disease,hsa05323,Rheumatoid arthritis,5/278,45/2914,0.1111111111111111,1.1646682653876899,0.3614688111668242,0.4312931890827266,0.9999072451192372,0.9401637704623658,CXCL2/CCL2/IL1B/IL6/TLR2,5
Cellular Processes,Cell growth and death,hsa04216,Ferroptosis,3/278,25/2914,0.12,1.257841726618705,0.42040645094884505,0.4317087737816052,0.9999072451192372,0.9401637704623658,CP/SLC39A14/ACSL5,3
Organismal Systems,Immune system,hsa04672,Intestinal immune network for IgA production,3/278,25/2914,0.12,1.257841726618705,0.42040645094884505,0.4317087737816052,0.9999072451192372,0.9401637704623658,IL15RA/IL6/CCR10,3
Human Diseases,Cancer: specific types,hsa05211,Renal cell carcinoma,3/278,25/2914,0.12,1.257841726618705,0.42040645094884505,0.4317087737816052,0.9999072451192372,0.9401637704623658,BAD/CDKN1A/CRK,3
Human Diseases,Drug resistance: antineoplastic,hsa01521,EGFR tyrosine kinase inhibitor resistance,4/278,35/2914,0.11428571428571428,1.1979445015416237,0.3825397498763887,0.43227855893643663,0.9999072451192372,0.9401637704623658,BAD/IL6/FGF2/SHC1,4
Environmental Information Processing,Signal transduction,hsa04015,Rap1 signaling pathway,11/278,107/2914,0.102803738317757,1.0775902642372084,0.2655203737487942,0.4444587708738662,0.9999072451192372,0.9401637704623658,NGFR/ANGPT2/ARAP3/RAC2/THBS1/FGF2/CRK/EFNA1/RAC3/FPR1/ITGB3,11
Human Diseases,Infectious disease: bacterial,hsa05131,Shigellosis,9/278,87/2914,0.10344827586206896,1.0843463160506077,0.2593479253826076,0.45171718076573764,0.9999072451192372,0.9401637704623658,NOD1/IL1R1/IL1B/TIFA/HK2/CRK/CD14/CASP4/H3C2,9
Metabolism,Lipid metabolism,hsa00120,Primary bile acid biosynthesis,1/278,6/2914,0.16666666666666666,1.7470023980815346,0.5947307000981117,0.45235507195059466,0.9999072451192372,0.9401637704623658,CH25H,1
Metabolism,Glycan biosynthesis and metabolism,hsa00603,Glycosphingolipid biosynthesis - globo and isoglobo series,1/278,6/2914,0.16666666666666666,1.7470023980815346,0.5947307000981117,0.45235507195059466,0.9999072451192372,0.9401637704623658,FUT1,1
Metabolism,Carbohydrate metabolism,hsa00640,Propanoate metabolism,1/278,6/2914,0.16666666666666666,1.7470023980815346,0.5947307000981117,0.45235507195059466,0.9999072451192372,0.9401637704623658,BCKDHA,1
Metabolism,Metabolism of cofactors and vitamins,hsa00860,Porphyrin metabolism,1/278,6/2914,0.16666666666666666,1.7470023980815346,0.5947307000981117,0.45235507195059466,0.9999072451192372,0.9401637704623658,CP,1
NA,NA,hsa03273,Virion - Lassa virus and SFTS virus,1/278,6/2914,0.16666666666666666,1.7470023980815346,0.5947307000981117,0.45235507195059466,0.9999072451192372,0.9401637704623658,CD209,1
Human Diseases,Immune disease,hsa05310,Asthma,1/278,6/2914,0.16666666666666666,1.7470023980815346,0.5947307000981117,0.45235507195059466,0.9999072451192372,0.9401637704623658,FCER1G,1
Organismal Systems,Immune system,hsa04658,Th1 and Th2 cell differentiation,4/278,36/2914,0.1111111111111111,1.1646682653876899,0.3228016184997733,0.4543350462642026,0.9999072451192372,0.9401637704623658,IL4R/JAK3/NOTCH1/JAG2,4
Environmental Information Processing,Signal transduction,hsa04024,cAMP signaling pathway,12/278,119/2914,0.10084033613445378,1.0570098543014328,0.20618280468152062,0.46548817115122965,0.9999072451192372,0.9401637704623658,BAD/ATP2A3/EDN1/POMC/ARAP3/EDN3/RAC2/ADCYAP1/CREB3L1/DRD5/RAC3/HTR1A,12
Human Diseases,Neurodegenerative disease,hsa05010,Alzheimer disease,12/278,121/2914,0.09917355371900827,1.039538617040252,0.1442442896683676,0.48971471725761817,0.9999072451192372,0.9401637704623658,BAD/WNT8A/ATP2A3/ATP5F1D/SLC39A14/APC2/IL1B/IL6/WNT9A/WNT7A/TUBB6/FZD8,12
Organismal Systems,Immune system,hsa04612,Antigen processing and presentation,2/278,17/2914,0.11764705882352941,1.2331781633516716,0.3130819481992019,0.4925969640341472,0.9999072451192372,0.9401637704623658,B2M/CD8B2,2
Metabolism,Metabolism of terpenoids and polyketides,hsa00900,Terpenoid backbone biosynthesis,1/278,7/2914,0.14285714285714285,1.4974306269270299,0.4278376132418507,0.5047090231190039,0.9999072451192372,0.9401637704623658,MVD,1
Environmental Information Processing,Signal transduction,hsa04390,Hippo signaling pathway,7/278,70/2914,0.1,1.048201438848921,0.13254524851100652,0.5077431307326099,0.9999072451192372,0.9401637704623658,WNT8A/APC2/WNT9A/WNT7A/FZD8/SCRIB/TEAD4,7
Organismal Systems,Sensory system,hsa04740,Olfactory transduction,5/278,49/2914,0.10204081632653061,1.0695933049478785,0.15952293283679145,0.5079420173637235,0.9999072451192372,0.9401637704623658,NCALD/RGS2/OR2AT4/OR51E1/OR8A1,5
Organismal Systems,Immune system,hsa04664,Fc epsilon RI signaling pathway,3/278,28/2914,0.10714285714285714,1.1230729701952724,0.21247775616644687,0.5083371384437274,0.9999072451192372,0.9401637704623658,RAC2/FCER1G/RAC3,3
Human Diseases,Neurodegenerative disease,hsa05020,Prion disease,8/278,81/2914,0.09876543209876543,1.035260680344613,0.10450326205980844,0.515010660473387,0.9999072451192372,0.9401637704623658,BAD/ATP5F1D/IL1B/RAC2/IL6/NOTCH1/CREB3L1/TUBB6,8
Metabolism,Metabolism of cofactors and vitamins,hsa00760,Nicotinate and nicotinamide metabolism,2/278,18/2914,0.1111111111111111,1.1646682653876899,0.2275447510625819,0.5238093614920246,0.9999072451192372,0.9401637704623658,NAMPT/PNP,2
Human Diseases,Cancer: specific types,hsa05219,Bladder cancer,2/278,18/2914,0.1111111111111111,1.1646682653876899,0.2275447510625819,0.5238093614920246,0.9999072451192372,0.9401637704623658,CDKN1A/THBS1,2
NA,NA,hsa04082,Neuroactive ligand signaling,12/278,124/2914,0.0967741935483871,1.014388489208633,0.053167210339192354,0.525598620649362,0.9999072451192372,0.9401637704623658,ACHE/SLC17A6/CHRNA4/POMC/GABRA6/CHRNA6/ADRA2A/GRM2/DRD5/P2RY6/HTR1A/SLC18A3,12
Cellular Processes,Cell growth and death,hsa04110,Cell cycle,5/278,50/2914,0.1,1.048201438848921,0.11162936007274162,0.5264877750410363,0.9999072451192372,0.9401637704623658,GADD45B/GADD45A/CDK2/CDKN1A/CDT1,5
Cellular Processes,Cellular community - eukaryotes,hsa04510,Focal adhesion,10/278,103/2914,0.0970873786407767,1.0176712998533213,0.05928934098377724,0.5272188527179302,0.9999072451192372,0.9401637704623658,BAD/COL9A3/RAC2/EMP1/THBS1/SHC1/CRK/RAC3/COL4A1/ITGB3,10
Metabolism,Carbohydrate metabolism,hsa00052,Galactose metabolism,1/278,8/2914,0.125,1.310251798561151,0.2853194864477935,0.5520743108977852,0.9999072451192372,0.9401637704623658,HK2,1
Metabolism,Metabolism of other amino acids,hsa00430,Taurine and hypotaurine metabolism,1/278,8/2914,0.125,1.310251798561151,0.2853194864477935,0.5520743108977852,0.9999072451192372,0.9401637704623658,GADL1,1
Organismal Systems,Nervous system,hsa04722,Neurotrophin signaling pathway,5/278,52/2914,0.09615384615384616,1.0078859988931932,0.01863131490033347,0.562626694542096,0.9999072451192372,0.9401637704623658,BAD/NGFR/SHC1/SH2B2/CRK,5
Cellular Processes,Cell growth and death,hsa04218,Cellular senescence,5/278,53/2914,0.09433962264150944,0.9888692819329443,-0.026553521550480536,0.5801706054974165,0.9999072451192372,0.9401637704623658,GADD45B/GADD45A/CDK2/CDKN1A/IL6,5
Metabolism,Metabolism of cofactors and vitamins,hsa00830,Retinol metabolism,2/278,20/2914,0.1,1.048201438848921,0.07023372037635492,0.5822591497600309,0.9999072451192372,0.9401637704623658,DHRS9/CYP26C1,2
Genetic Information Processing,Information processing in viruses,hsa03250,Viral life cycle - HIV-1,2/278,20/2914,0.1,1.048201438848921,0.07023372037635492,0.5822591497600309,0.9999072451192372,0.9401637704623658,ELL2/MAP1S,2
Human Diseases,Cancer: overview,hsa05204,Chemical carcinogenesis - DNA adducts,2/278,20/2914,0.1,1.048201438848921,0.07023372037635492,0.5822591497600309,0.9999072451192372,0.9401637704623658,CYP3A43/CYP1B1,2
Organismal Systems,Development and regeneration,hsa04360,Axon guidance,9/278,97/2914,0.09278350515463918,0.9725580360453905,-0.08925397574353731,0.588035108014727,0.9999072451192372,0.9401637704623658,LIMK1/PLXNA1/RAC2/NTN3/EFNA1/RAC3/LIMK2/EPHB3/NTNG2,9
Organismal Systems,Circulatory system,hsa04270,Vascular smooth muscle contraction,6/278,65/2914,0.09230769230769231,0.9675705589374654,-0.08585584253529205,0.597475982303899,0.9999072451192372,0.9401637704623658,EDN1/CALCA/EDN3/RAMP2/ADM/PPP1R14A,6
Cellular Processes,Cellular community - eukaryotes,hsa04520,Adherens junction,3/278,32/2914,0.09375,0.9826888489208633,-0.03197230040314872,0.6014148414545386,0.9999072451192372,0.9401637704623658,RAC2/RAC3/CDH5,3
Human Diseases,Immune disease,hsa05322,Systemic lupus erythematosus,5/278,55/2914,0.09090909090909091,0.9529103989535646,-0.11447725718248032,0.6141049384514907,0.9999072451192372,0.9401637704623658,FCGR2A/FCGR1A/C1R/FCGR3A/H3C2,5
Human Diseases,Cancer: overview,hsa05230,Central carbon metabolism in cancer,3/278,33/2914,0.09090909090909091,0.9529103989535646,-0.08833448657279311,0.6228028797194147,0.9999072451192372,0.9401637704623658,SLC1A5/PDK1/HK2,3
Genetic Information Processing,Chromosome,hsa03083,Polycomb repressive complex,1/278,10/2914,0.1,1.048201438848921,0.04957715873490117,0.6336892554553816,0.9999072451192372,0.9401637704623658,FBRSL1,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04130,SNARE interactions in vesicular transport,1/278,10/2914,0.1,1.048201438848921,0.04957715873490117,0.6336892554553816,0.9999072451192372,0.9401637704623658,STX11,1
Human Diseases,Endocrine and metabolic disease,hsa04940,Type I diabetes mellitus,1/278,10/2914,0.1,1.048201438848921,0.04957715873490117,0.6336892554553816,0.9999072451192372,0.9401637704623658,IL1B,1
Metabolism,Metabolism of other amino acids,hsa00480,Glutathione metabolism,2/278,22/2914,0.09090909090909091,0.9529103989535646,-0.07198750876735849,0.6352700402940143,0.9999072451192372,0.9401637704623658,CHAC1/OPLAH,2
Metabolism,Lipid metabolism,hsa00565,Ether lipid metabolism,2/278,22/2914,0.09090909090909091,0.9529103989535646,-0.07198750876735849,0.6352700402940143,0.9999072451192372,0.9401637704623658,LPCAT1/PLD4,2
Genetic Information Processing,Translation,hsa03010,Ribosome,2/278,22/2914,0.09090909090909091,0.9529103989535646,-0.07198750876735849,0.6352700402940143,0.9999072451192372,0.9401637704623658,RNA5S9/MRPL12,2
Organismal Systems,Digestive system,hsa04973,Carbohydrate digestion and absorption,2/278,22/2914,0.09090909090909091,0.9529103989535646,-0.07198750876735849,0.6352700402940143,0.9999072451192372,0.9401637704623658,SLC2A5/HK2,2
Cellular Processes,Cell motility,hsa04810,Regulation of actin cytoskeleton,9/278,101/2914,0.0891089108910891,0.9340408861029987,-0.21906377672559946,0.6380796385375085,0.9999072451192372,0.9401637704623658,LIMK1/APC2/RAC2/FGF2/CRK/BDKRB2/RAC3/LIMK2/ITGB3,9
Human Diseases,Cancer: overview,hsa05203,Viral carcinogenesis,6/278,68/2914,0.08823529411764706,0.9248836225137538,-0.20351273066731554,0.6425545326362518,0.9999072451192372,0.9401637704623658,BAD/JAK3/CDK2/CDKN1A/CREB3L1/SCRIB,6
Organismal Systems,Endocrine system,hsa04927,Cortisol synthesis and secretion,3/278,34/2914,0.08823529411764706,0.9248836225137538,-0.14305326936950818,0.6433975266800669,0.9999072451192372,0.9401637704623658,CACNA1G/POMC/CREB3L1,3
Human Diseases,Infectious disease: viral,hsa05160,Hepatitis C,5/278,57/2914,0.08771929824561403,0.9194749463587025,-0.19935781623813484,0.6463952817782737,0.9999072451192372,0.9401637704623658,BAD/CDK2/CDKN1A/IFNA5/SOCS3,5
Environmental Information Processing,Signal transduction,hsa04012,ErbB signaling pathway,4/278,46/2914,0.08695652173913043,0.9114795120425399,-0.19649571264369986,0.6526353324160105,0.9999072451192372,0.9401637704623658,BAD/CDKN1A/SHC1/CRK,4
Organismal Systems,Endocrine system,hsa04919,Thyroid hormone signaling pathway,4/278,46/2914,0.08695652173913043,0.9114795120425399,-0.19649571264369986,0.6526353324160105,0.9999072451192372,0.9401637704623658,BAD/ATP2A3/NOTCH1/ITGB3,4
Environmental Information Processing,Signal transduction,hsa04330,Notch signaling pathway,2/278,23/2914,0.08695652173913043,0.9114795120425399,-0.1383896492922202,0.659741304594643,0.9999072451192372,0.9401637704623658,NOTCH1/JAG2,2
Organismal Systems,Endocrine system,hsa04915,Estrogen signaling pathway,5/278,58/2914,0.08620689655172414,0.9036219300421732,-0.24073157515703036,0.6618933621643373,0.9999072451192372,0.9401637704623658,FKBP5/POMC/CTSD/CREB3L1/SHC1,5
Organismal Systems,Sensory system,hsa04742,Taste transduction,3/278,35/2914,0.08571428571428572,0.8984583761562179,-0.1962353441733501,0.6631899299060324,0.9999072451192372,0.9401637704623658,GABRA6/HTR1A/CALHM1,3
Genetic Information Processing,Replication and repair,hsa03460,Fanconi anemia pathway,1/278,11/2914,0.09090909090909091,0.9529103989535646,-0.050806323946370593,0.6687561931218429,0.9999072451192372,0.9401637704623658,TELO2,1
Environmental Information Processing,Signal transduction,hsa04392,Hippo signaling pathway - multiple species,1/278,11/2914,0.09090909090909091,0.9529103989535646,-0.050806323946370593,0.6687561931218429,0.9999072451192372,0.9401637704623658,TEAD4,1
Human Diseases,Endocrine and metabolic disease,hsa04950,Maturity onset diabetes of the young,1/278,11/2914,0.09090909090909091,0.9529103989535646,-0.050806323946370593,0.6687561931218429,0.9999072451192372,0.9401637704623658,BHLHA15,1
Organismal Systems,Endocrine system,hsa04924,Renin secretion,3/278,36/2914,0.08333333333333333,0.8735011990407673,-0.24797745693004442,0.682176737509835,0.9999072451192372,0.9401637704623658,EDN1/EDN3/ADCYAP1,3
Environmental Information Processing,Signal transduction,hsa04014,Ras signaling pathway,9/278,105/2914,0.08571428571428572,0.8984583761562179,-0.3440985333756309,0.6846567603102873,0.9999072451192372,0.9401637704623658,BAD/NGFR/ANGPT2/RASAL3/RAC2/FGF2/SHC1/EFNA1/RAC3,9
Metabolism,Amino acid metabolism,hsa00340,Histidine metabolism,1/278,12/2914,0.08333333333333333,0.8735011990407673,-0.14257660371866485,0.7004770950550596,0.9999072451192372,0.9401637704623658,HDC,1
Metabolism,Glycan biosynthesis and metabolism,hsa00601,Glycosphingolipid biosynthesis - lacto and neolacto series,1/278,12/2914,0.08333333333333333,0.8735011990407673,-0.14257660371866485,0.7004770950550596,0.9999072451192372,0.9401637704623658,FUT1,1
Cellular Processes,Cell growth and death,hsa04215,Apoptosis - multiple species,1/278,12/2914,0.08333333333333333,0.8735011990407673,-0.14257660371866485,0.7004770950550596,0.9999072451192372,0.9401637704623658,NGFR,1
Organismal Systems,Environmental adaptation,hsa04710,Circadian rhythm,1/278,12/2914,0.08333333333333333,0.8735011990407673,-0.14257660371866485,0.7004770950550596,0.9999072451192372,0.9401637704623658,NFIL3,1
Human Diseases,Immune disease,hsa05320,Autoimmune thyroid disease,1/278,12/2914,0.08333333333333333,0.8735011990407673,-0.14257660371866485,0.7004770950550596,0.9999072451192372,0.9401637704623658,IFNA5,1
Environmental Information Processing,Signal transduction,hsa04350,TGF-beta signaling pathway,4/278,49/2914,0.08163265306122448,0.8556746439583026,-0.3308249851868488,0.7018602500115356,0.9999072451192372,0.9401637704623658,HAMP/THBS1/INHBB/NRROS,4
Organismal Systems,Immune system,hsa04622,RIG-I-like receptor signaling pathway,2/278,25/2914,0.08,0.8385611510791368,-0.26322323547131954,0.7047236573737972,0.9999072451192372,0.9401637704623658,IFNA5/ISG15,2
Environmental Information Processing,Signal transduction,hsa04150,mTOR signaling pathway,5/278,61/2914,0.08196721311475409,0.8591815072532137,-0.36090563296238287,0.705705734198594,0.9999072451192372,0.9401637704623658,WNT8A/TELO2/WNT9A/WNT7A/FZD8,5
Organismal Systems,Endocrine system,hsa04935,"Growth hormone synthesis, secretion and action",5/278,61/2914,0.08196721311475409,0.8591815072532137,-0.36090563296238287,0.705705734198594,0.9999072451192372,0.9401637704623658,CREB3L1/SHC1/CRK/SOCS3/SSTR3,5
Organismal Systems,Endocrine system,hsa04925,Aldosterone synthesis and secretion,4/278,51/2914,0.0784313725490196,0.822118775567781,-0.41612562607043424,0.7317811240338226,0.9999072451192372,0.9401637704623658,CACNA1G/POMC/CREB3L1/KCNK9,4
Human Diseases,Cardiovascular disease,hsa05410,Hypertrophic cardiomyopathy,4/278,51/2914,0.0784313725490196,0.822118775567781,-0.41612562607043424,0.7317811240338226,0.9999072451192372,0.9401637704623658,ATP2A3/EDN1/IL6/ITGB3,4
Cellular Processes,Transport and catabolism,hsa04142,Lysosome,3/278,39/2914,0.07692307692307693,0.8063087991145546,-0.3954059571807311,0.7343394585484557,0.9999072451192372,0.9401637704623658,SLC11A1/CTSD/HYAL3,3
Organismal Systems,Endocrine system,hsa04918,Thyroid hormone synthesis,3/278,39/2914,0.07692307692307693,0.8063087991145546,-0.3954059571807311,0.7343394585484557,0.9999072451192372,0.9401637704623658,TTR/DUOX1/CREB3L1,3
Human Diseases,Drug resistance: antineoplastic,hsa01524,Platinum drug resistance,2/278,27/2914,0.07407407407407407,0.7764455102584599,-0.3789324727327829,0.7446569462807555,0.9999072451192372,0.9401637704623658,BAD/CDKN1A,2
Human Diseases,Cardiovascular disease,hsa05416,Viral myocarditis,2/278,27/2914,0.07407407407407407,0.7764455102584599,-0.3789324727327829,0.7446569462807555,0.9999072451192372,0.9401637704623658,RAC2/RAC3,2
Environmental Information Processing,Signaling molecules and interaction,hsa04514,Cell adhesion molecules,7/278,88/2914,0.07954545454545454,0.8337965990843689,-0.514061525718057,0.7496802781719598,0.9999072451192372,0.9401637704623658,SELE/LRRC4B/F11R/CDH5/NTNG2/CD8B2/PECAM1,7
Metabolism,Lipid metabolism,hsa00564,Glycerophospholipid metabolism,3/278,40/2914,0.075,0.7861510791366906,-0.4421947826262997,0.7501588936140997,0.9999072451192372,0.9401637704623658,ACHE/LPCAT1/PLD4,3
Metabolism,Carbohydrate metabolism,hsa00051,Fructose and mannose metabolism,1/278,14/2914,0.07142857142857142,0.7487153134635149,-0.30602082342490483,0.755123548374132,0.9999072451192372,0.9401637704623658,HK2,1
Metabolism,Lipid metabolism,hsa00071,Fatty acid degradation,1/278,14/2914,0.07142857142857142,0.7487153134635149,-0.30602082342490483,0.755123548374132,0.9999072451192372,0.9401637704623658,ACSL5,1
Metabolism,Amino acid metabolism,hsa00280,"Valine, leucine and isoleucine degradation",1/278,14/2914,0.07142857142857142,0.7487153134635149,-0.30602082342490483,0.755123548374132,0.9999072451192372,0.9401637704623658,BCKDHA,1
Metabolism,Metabolism of other amino acids,hsa00410,beta-Alanine metabolism,1/278,14/2914,0.07142857142857142,0.7487153134635149,-0.30602082342490483,0.755123548374132,0.9999072451192372,0.9401637704623658,GADL1,1
Metabolism,Glycan biosynthesis and metabolism,hsa00534,Glycosaminoglycan biosynthesis - heparan sulfate / heparin,1/278,14/2914,0.07142857142857142,0.7487153134635149,-0.30602082342490483,0.755123548374132,0.9999072451192372,0.9401637704623658,HS3ST1,1
Metabolism,Global and overview maps,hsa01250,Biosynthesis of nucleotide sugars,1/278,14/2914,0.07142857142857142,0.7487153134635149,-0.30602082342490483,0.755123548374132,0.9999072451192372,0.9401637704623658,HK2,1
Organismal Systems,Excretory system,hsa04964,Proximal tubule bicarbonate reclamation,1/278,14/2914,0.07142857142857142,0.7487153134635149,-0.30602082342490483,0.755123548374132,0.9999072451192372,0.9401637704623658,SLC25A10,1
Organismal Systems,Immune system,hsa04670,Leukocyte transendothelial migration,4/278,53/2914,0.07547169811320754,0.7910954255463554,-0.4983642642218203,0.7594044057562872,0.9999072451192372,0.9401637704623658,RAC2/F11R/CDH5/PECAM1,4
Metabolism,Global and overview maps,hsa01230,Biosynthesis of amino acids,2/278,28/2914,0.07142857142857142,0.7487153134635149,-0.4338272349285704,0.7628353930374498,0.9999072451192372,0.9401637704623658,GPT/ACY1,2
Human Diseases,Endocrine and metabolic disease,hsa04932,Non-alcoholic fatty liver disease,3/278,41/2914,0.07317073170731707,0.7669766625723811,-0.4879142145578656,0.7652175727832784,0.9999072451192372,0.9401637704623658,IL1B/IL6/SOCS3,3
Human Diseases,Cancer: overview,hsa05207,Chemical carcinogenesis - receptor activation,6/278,78/2914,0.07692307692307693,0.8063087991145546,-0.563020252468684,0.7693308520145941,0.9999072451192372,0.9401637704623658,BAD/CHRNA4/BCL6/CYP1B1/FGF2/CREB3L1,6
Genetic Information Processing,"Folding, sorting and degradation",hsa03018,RNA degradation,1/278,15/2914,0.06666666666666667,0.6988009592326139,-0.3797476050555687,0.778597911667922,0.9999072451192372,0.9401637704623658,PARN,1
Metabolism,Global and overview maps,hsa01240,Biosynthesis of cofactors,3/278,42/2914,0.07142857142857142,0.7487153134635149,-0.5326211254135282,0.7795331759475094,0.9999072451192372,0.9401637704623658,MTHFD2/NME3/PDXP,3
Human Diseases,Substance dependence,hsa05030,Cocaine addiction,2/278,29/2914,0.06896551724137931,0.7228975440337385,-0.48695227871850433,0.7798842481615385,0.9999072451192372,0.9401637704623658,CREB3L1/GRM2,2
Organismal Systems,Nervous system,hsa04725,Cholinergic synapse,5/278,67/2914,0.07462686567164178,0.7822398797380006,-0.585520294779464,0.7810636297066867,0.9999072451192372,0.9401637704623658,ACHE/CHRNA4/CHRNA6/CREB3L1/SLC18A3,5
Organismal Systems,Endocrine system,hsa03320,PPAR signaling pathway,2/278,30/2914,0.06666666666666667,0.6988009592326139,-0.5384390149701697,0.7958527233725272,0.9999072451192372,0.9401637704623658,ANGPTL4/ACSL5,2
Metabolism,Amino acid metabolism,hsa00380,Tryptophan metabolism,1/278,16/2914,0.0625,0.6551258992805755,-0.4491499121898893,0.7998292950954204,0.9999072451192372,0.9401637704623658,CYP1B1,1
Metabolism,Global and overview maps,hsa01212,Fatty acid metabolism,1/278,16/2914,0.0625,0.6551258992805755,-0.4491499121898893,0.7998292950954204,0.9999072451192372,0.9401637704623658,ACSL5,1
Organismal Systems,Excretory system,hsa04962,Vasopressin-regulated water reabsorption,1/278,16/2914,0.0625,0.6551258992805755,-0.4491499121898893,0.7998292950954204,0.9999072451192372,0.9401637704623658,CREB3L1,1
Environmental Information Processing,Signal transduction,hsa04072,Phospholipase D signaling pathway,5/278,69/2914,0.07246376811594203,0.75956626003545,-0.6562944917863169,0.8026158720963767,0.9999072451192372,0.9401637704623658,SPHK2/FCER1G/SHC1/GRM2/CXCR2,5
Cellular Processes,Cell motility,hsa04820,Cytoskeleton in muscle cells,9/278,119/2914,0.07563025210084033,0.7927573907260745,-0.7495171309101298,0.8167714193249758,0.9999072451192372,0.9401637704623658,COL5A3/COL9A3/LMNB1/DSC2/THBS1/SPTBN5/XIRP1/COL4A1/ITGB3,9
Environmental Information Processing,Signaling molecules and interaction,hsa04512,ECM-receptor interaction,4/278,58/2914,0.06896551724137931,0.7228975440337385,-0.6921420063073431,0.8188161396013309,0.9999072451192372,0.9401637704623658,COL9A3/THBS1/COL4A1/ITGB3,4
Metabolism,Amino acid metabolism,hsa00250,"Alanine, aspartate and glutamate metabolism",1/278,17/2914,0.058823529411764705,0.6165890816758358,-0.5147953631006842,0.8190313157867499,0.9999072451192372,0.9401637704623658,GPT,1
Metabolism,Amino acid metabolism,hsa00310,Lysine degradation,1/278,17/2914,0.058823529411764705,0.6165890816758358,-0.5147953631006842,0.8190313157867499,0.9999072451192372,0.9401637704623658,PLOD2,1
Metabolism,Lipid metabolism,hsa00600,Sphingolipid metabolism,1/278,17/2914,0.058823529411764705,0.6165890816758358,-0.5147953631006842,0.8190313157867499,0.9999072451192372,0.9401637704623658,SPHK2,1
Human Diseases,Cardiovascular disease,hsa05415,Diabetic cardiomyopathy,4/278,59/2914,0.06779661016949153,0.710645043287404,-0.7290776971653768,0.8291338022278225,0.9999072451192372,0.9401637704623658,ATP2A3/ATP5F1D/CTSD/RAC2,4
Human Diseases,Infectious disease: parasitic,hsa05145,Toxoplasmosis,3/278,46/2914,0.06521739130434782,0.6836096340319049,-0.7023159481947087,0.8297773018748582,0.9999072451192372,0.9401637704623658,BAD/TLR2/LY96,3
Metabolism,Metabolism of cofactors and vitamins,hsa00670,One carbon pool by folate,1/278,18/2914,0.05555555555555555,0.5823341326938449,-0.5771462739330052,0.8363973130982044,0.9999072451192372,0.9401637704623658,MTHFD2,1
Cellular Processes,Cellular community - eukaryotes,hsa04530,Tight junction,4/278,60/2914,0.06666666666666667,0.6988009592326139,-0.7654594033399168,0.8389609435031506,0.9999072451192372,0.9401637704623658,YBX3/F11R/RUNX1/SCRIB,4
Human Diseases,Cardiovascular disease,hsa05412,Arrhythmogenic right ventricular cardiomyopathy,3/278,47/2914,0.06382978723404255,0.6690647482014388,-0.742673711182052,0.8406970700092915,0.9999072451192372,0.9401637704623658,ATP2A3/DSC2/ITGB3,3
Metabolism,Global and overview maps,hsa01232,Nucleotide metabolism,2/278,34/2914,0.058823529411764705,0.6165890816758358,-0.730176124218447,0.8499269516466622,0.9999072451192372,0.9401637704623658,NME3/PNP,2
Organismal Systems,Nervous system,hsa04721,Synaptic vesicle cycle,3/278,48/2914,0.0625,0.6551258992805755,-0.7822814714921207,0.8510081953296742,0.9999072451192372,0.9401637704623658,SLC17A6/CPLX1/SLC18A3,3
Organismal Systems,Endocrine system,hsa04928,"Parathyroid hormone synthesis, secretion and action",3/278,48/2914,0.0625,0.6551258992805755,-0.7822814714921207,0.8510081953296742,0.9999072451192372,0.9401637704623658,CDKN1A/CREB3L1/MMP17,3
Metabolism,Lipid metabolism,hsa00140,Steroid hormone biosynthesis,1/278,19/2914,0.05263157894736842,0.5516849678152215,-0.6365840529715316,0.8521022671585288,0.9999072451192372,0.9401637704623658,CYP1B1,1
Metabolism,Nucleotide metabolism,hsa00240,Pyrimidine metabolism,1/278,19/2914,0.05263157894736842,0.5516849678152215,-0.6365840529715316,0.8521022671585288,0.9999072451192372,0.9401637704623658,NME3,1
Genetic Information Processing,Chromosome,hsa03082,ATP-dependent chromatin remodeling,1/278,19/2914,0.05263157894736842,0.5516849678152215,-0.6365840529715316,0.8521022671585288,0.9999072451192372,0.9401637704623658,MBD3,1
Environmental Information Processing,Signal transduction,hsa04022,cGMP-PKG signaling pathway,6/278,88/2914,0.06818181818181818,0.7146827992151732,-0.8824765001259318,0.8594542845978712,0.9999072451192372,0.9401637704623658,BAD/ATP2A3/RGS2/ADRA2A/CREB3L1/BDKRB2,6
NA,NA,hsa04382,Cornified envelope formation,4/278,63/2914,0.06349206349206349,0.6655247230786799,-0.8714763892765375,0.8656474612622244,0.9999072451192372,0.9401637704623658,S100A8/S100A9/COL4A1/S100A3,4
Human Diseases,Neurodegenerative disease,hsa05022,Pathways of neurodegeneration - multiple diseases,12/278,163/2914,0.0736196319018405,0.7716820408703712,-0.9741111581127162,0.8690775356256242,0.9999072451192372,0.9401637704623658,BAD/TNFRSF1B/WNT8A/ATP2A3/ATP5F1D/APC2/IL1B/IL6/WNT9A/WNT7A/TUBB6/FZD8,12
Human Diseases,Infectious disease: bacterial,hsa05100,Bacterial invasion of epithelial cells,2/278,36/2914,0.05555555555555555,0.5823341326938449,-0.8187565323598621,0.8717777356915427,0.9999072451192372,0.9401637704623658,SHC1/CRK,2
Human Diseases,Cancer: overview,hsa05208,Chemical carcinogenesis - reactive oxygen species,4/278,66/2914,0.06060606060606061,0.6352735993023764,-0.9731708985664635,0.8884651438584266,0.9999072451192372,0.9401637704623658,BAD/ATP5F1D/CYP1B1/SLC26A1,4
Metabolism,Global and overview maps,hsa01200,Carbon metabolism,2/278,38/2914,0.05263157894736842,0.5516849678152215,-0.9032346629973894,0.8906746875625658,0.9999072451192372,0.9401637704623658,HK2/GPT,2
Metabolism,Xenobiotics biodegradation and metabolism,hsa00980,Metabolism of xenobiotics by cytochrome P450,1/278,22/2914,0.045454545454545456,0.4764551994767823,-0.8003611217815357,0.8907606408623121,0.9999072451192372,0.9401637704623658,CYP1B1,1
Metabolism,Xenobiotics biodegradation and metabolism,hsa00983,Drug metabolism - other enzymes,1/278,22/2914,0.045454545454545456,0.4764551994767823,-0.8003611217815357,0.8907606408623121,0.9999072451192372,0.9401637704623658,NME3,1
Human Diseases,Substance dependence,hsa05031,Amphetamine addiction,2/278,39/2914,0.05128205128205128,0.537539199409703,-0.9440787949067551,0.8991252404822474,0.9999072451192372,0.9401637704623658,CREB3L1/ARC,2
Cellular Processes,Transport and catabolism,hsa04146,Peroxisome,1/278,23/2914,0.043478260869565216,0.4557397560212699,-0.8508762889344995,0.9012615197835698,0.9999072451192372,0.9401637704623658,ACSL5,1
Cellular Processes,Cell motility,hsa04814,Motor proteins,5/278,82/2914,0.06097560975609756,0.6391472188103177,-1.0762428911929425,0.9046299606544004,0.9999072451192372,0.9401637704623658,KIF26A/MYO1G/MYO5B/MYO7B/TUBB6,5
Organismal Systems,Endocrine system,hsa04914,Progesterone-mediated oocyte maturation,2/278,40/2914,0.05,0.5241007194244605,-0.9840600461136997,0.9069655745279395,0.9999072451192372,0.9401637704623658,CDK2/CPEB1,2
Organismal Systems,Digestive system,hsa04971,Gastric acid secretion,2/278,40/2914,0.05,0.5241007194244605,-0.9840600461136997,0.9069655745279395,0.9999072451192372,0.9401637704623658,KCNJ16/SLC9A4,2
Organismal Systems,Digestive system,hsa04976,Bile secretion,2/278,40/2914,0.05,0.5241007194244605,-0.9840600461136997,0.9069655745279395,0.9999072451192372,0.9401637704623658,ABCB4/SLC4A5,2
Organismal Systems,Endocrine system,hsa04926,Relaxin signaling pathway,4/278,69/2914,0.057971014492753624,0.60765300802836,-1.0709610462237253,0.9078357316434214,0.9999072451192372,0.9401637704623658,EDN1/CREB3L1/SHC1/COL4A1,4
Metabolism,Carbohydrate metabolism,hsa00010,Glycolysis / Gluconeogenesis,1/278,24/2914,0.041666666666666664,0.43675059952038364,-0.8996578524070875,0.9107562612225762,0.9999072451192372,0.9401637704623658,HK2,1
Human Diseases,Neurodegenerative disease,hsa05017,Spinocerebellar ataxia,2/278,41/2914,0.04878048780487805,0.5113177750482542,-1.0232237104997406,0.9142347028225374,0.9999072451192372,0.9401637704623658,ATP2A3/BEAN1,2
Organismal Systems,Endocrine system,hsa04913,Ovarian steroidogenesis,1/278,25/2914,0.04,0.4192805755395684,-0.9468529218914841,0.9193409530496086,0.9999072451192372,0.9401637704623658,CYP1B1,1
Cellular Processes,Transport and catabolism,hsa04140,Autophagy - animal,2/278,42/2914,0.047619047619047616,0.4991435423090099,-1.0616115683089005,0.9209697791662887,0.9999072451192372,0.9401637704623658,BAD/CTSD,2
Metabolism,Lipid metabolism,hsa00590,Arachidonic acid metabolism,1/278,26/2914,0.038461538461538464,0.4031543995572773,-0.9925902701695651,0.9271025366606189,0.9999072451192372,0.9401637704623658,PTGES,1
Cellular Processes,Cell growth and death,hsa04114,Oocyte meiosis,2/278,43/2914,0.046511627906976744,0.4875355529529864,-1.0992622393702727,0.9272060965444386,0.9999072451192372,0.9401637704623658,CDK2/CPEB1,2
Organismal Systems,Endocrine system,hsa04922,Glucagon signaling pathway,2/278,43/2914,0.046511627906976744,0.4875355529529864,-1.0992622393702727,0.9272060965444386,0.9999072451192372,0.9401637704623658,PYGL/CREB3L1,2
Human Diseases,Cancer: overview,hsa05231,Choline metabolism in cancer,2/278,43/2914,0.046511627906976744,0.4875355529529864,-1.0992622393702727,0.9272060965444386,0.9999072451192372,0.9401637704623658,RAC2/RAC3,2
Organismal Systems,Sensory system,hsa04750,Inflammatory mediator regulation of TRP channels,3/278,59/2914,0.05084745762711865,0.5329837824655531,-1.1767246439710886,0.9311573961953213,0.9999072451192372,0.9401637704623658,IL1R1/IL1B/BDKRB2,3
Environmental Information Processing,Membrane transport,hsa02010,ABC transporters,1/278,27/2914,0.037037037037037035,0.38822275512922994,-1.036983262687091,0.9341196747521522,0.9999072451192372,0.9401637704623658,ABCB4,1
Environmental Information Processing,Signal transduction,hsa04020,Calcium signaling pathway,9/278,142/2914,0.06338028169014084,0.6643530246225555,-1.3315277887085435,0.937285472133595,0.9999072451192372,0.9401637704623658,CACNA1G/SPHK2/ATP2A3/ITPKC/NTSR1/FGF2/GNA14/BDKRB2/DRD5,9
Organismal Systems,Immune system,hsa04660,T cell receptor signaling pathway,2/278,45/2914,0.044444444444444446,0.465867306155076,-1.1724925224352998,0.9383144301373332,0.9999072451192372,0.9401637704623658,CARD11/CD8B2,2
Organismal Systems,Circulatory system,hsa04260,Cardiac muscle contraction,1/278,28/2914,0.03571428571428571,0.37435765673175747,-1.0801322260235875,0.940463537037882,0.9999072451192372,0.9401637704623658,ATP2A3,1
Organismal Systems,Excretory system,hsa04961,Endocrine and other factor-regulated calcium reabsorption,1/278,28/2914,0.03571428571428571,0.37435765673175747,-1.0801322260235875,0.940463537037882,0.9999072451192372,0.9401637704623658,BDKRB2,1
Organismal Systems,Immune system,hsa04611,Platelet activation,3/278,61/2914,0.04918032786885246,0.5155089043519282,-1.241708827646121,0.9405459266676062,0.9999072451192372,0.9401637704623658,FCGR2A/FCER1G/ITGB3,3
Organismal Systems,Environmental adaptation,hsa04714,Thermogenesis,3/278,61/2914,0.04918032786885246,0.5155089043519282,-1.241708827646121,0.9405459266676062,0.9999072451192372,0.9401637704623658,ATP5F1D/CREB3L1/ACSL5,3
Organismal Systems,Nervous system,hsa04727,GABAergic synapse,2/278,46/2914,0.043478260869565216,0.4557397560212699,-1.2081361837457176,0.9432479359674457,0.9999072451192372,0.9401637704623658,SLC38A5/GABRA6,2
Metabolism,Energy metabolism,hsa00190,Oxidative phosphorylation,1/278,29/2914,0.034482758620689655,0.36144877201686926,-1.1221263790702147,0.9461985116406084,0.9999072451192372,0.9401637704623658,ATP5F1D,1
Organismal Systems,Digestive system,hsa04979,Cholesterol metabolism,1/278,29/2914,0.034482758620689655,0.36144877201686926,-1.1221263790702147,0.9461985116406084,0.9999072451192372,0.9401637704623658,ANGPTL4,1
Organismal Systems,Digestive system,hsa04972,Pancreatic secretion,2/278,47/2914,0.0425531914893617,0.4460431654676259,-1.2431712121960437,0.9478057522322525,0.9999072451192372,0.9401637704623658,ATP2A3/CPB1,2
Human Diseases,Cancer: overview,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/278,30/2914,0.03333333333333333,0.34940047961630694,-1.1630454200748968,0.9513828491670939,0.9999072451192372,0.9401637704623658,TLR2,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04120,Ubiquitin mediated proteolysis,1/278,32/2914,0.03125,0.32756294964028776,-1.2419370195560722,0.9603053712615885,0.9999072451192372,0.9401637704623658,SOCS3,1
Cellular Processes,Transport and catabolism,hsa04137,Mitophagy - animal,1/278,32/2914,0.03125,0.32756294964028776,-1.2419370195560722,0.9603053712615885,0.9999072451192372,0.9401637704623658,CITED2,1
Organismal Systems,Endocrine system,hsa04911,Insulin secretion,2/278,51/2914,0.0392156862745098,0.4110593877838905,-1.3777355185123412,0.9627856465043556,0.9999072451192372,0.9401637704623658,ADCYAP1/CREB3L1,2
Metabolism,Carbohydrate metabolism,hsa00562,Inositol phosphate metabolism,1/278,33/2914,0.030303030303030304,0.3176367996511882,-1.280032143392788,0.9641343465528025,0.9999072451192372,0.9401637704623658,ITPKC,1
Human Diseases,Neurodegenerative disease,hsa05012,Parkinson disease,3/278,68/2914,0.04411764705882353,0.4624418112568769,-1.4564058936910278,0.9648624001852822,0.9999072451192372,0.9401637704623658,ATP5F1D/SLC39A14/TUBB6,3
Human Diseases,Cardiovascular disease,hsa05414,Dilated cardiomyopathy,2/278,54/2914,0.037037037037037035,0.38822275512922994,-1.4734218977257931,0.9712197316056714,0.9999072451192372,0.9401637704623658,ATP2A3/ITGB3,2
Organismal Systems,Environmental adaptation,hsa04713,Circadian entrainment,2/278,55/2914,0.03636363636363636,0.38116415958142574,-1.5044219548064268,0.9735979835484829,0.9999072451192372,0.9401637704623658,CACNA1G/ADCYAP1,2
Organismal Systems,Endocrine system,hsa04929,GnRH secretion,1/278,37/2914,0.02702702702702703,0.28329768617538403,-1.4245892898303774,0.9761050730165997,0.9999072451192372,0.9401637704623658,CACNA1G,1
Environmental Information Processing,Signal transduction,hsa04152,AMPK signaling pathway,1/278,39/2914,0.02564102564102564,0.2687695997048515,-1.492751632632779,0.9805005487182201,0.9999072451192372,0.9401637704623658,CREB3L1,1
Cellular Processes,Transport and catabolism,hsa04144,Endocytosis,3/278,76/2914,0.039473684210526314,0.4137637258614161,-1.6814858823868082,0.9811447421133992,0.9999072451192372,0.9401637704623658,ARAP3/VPS28/CXCR2,3
Metabolism,Nucleotide metabolism,hsa00230,Purine metabolism,2/278,59/2914,0.03389830508474576,0.355322521643702,-1.6243715907768002,0.9813520705729238,0.9999072451192372,0.9401637704623658,NME3/PNP,2
Organismal Systems,Aging,hsa04211,Longevity regulating pathway,1/278,40/2914,0.025,0.26205035971223023,-1.5259253096010996,0.9823860608769452,0.9999072451192372,0.9401637704623658,CREB3L1,1
Human Diseases,Neurodegenerative disease,hsa05014,Amyotrophic lateral sclerosis,4/278,96/2914,0.041666666666666664,0.43675059952038364,-1.822157016003708,0.9860162654114484,0.9999072451192372,0.9401637704623658,BAD/TNFRSF1B/ATP5F1D/TUBB6,4
Cellular Processes,Cellular community - eukaryotes,hsa04540,Gap junction,1/278,43/2914,0.023255813953488372,0.2437677764764932,-1.622156487741963,0.9870203886744757,0.9999072451192372,0.9401637704623658,TUBB6,1
Organismal Systems,Nervous system,hsa04724,Glutamatergic synapse,2/278,64/2914,0.03125,0.32756294964028776,-1.766196943080093,0.9879928704082073,0.9999072451192372,0.9401637704623658,SLC17A6/GRM2,2
Environmental Information Processing,Signal transduction,hsa04070,Phosphatidylinositol signaling system,1/278,44/2914,0.022727272727272728,0.23822759973839114,-1.6532196586628367,0.9882772092765293,0.9999072451192372,0.9401637704623658,ITPKC,1
Organismal Systems,Digestive system,hsa04970,Salivary secretion,1/278,47/2914,0.02127659574468085,0.22302158273381295,-1.7436687132100355,0.9913654125115952,0.9999072451192372,0.9401637704623658,LYZ,1
Human Diseases,Substance dependence,hsa05034,Alcoholism,3/278,86/2914,0.03488372093023256,0.3656516647147398,-1.938908278140117,0.991571435570467,0.9999072451192372,0.9401637704623658,CREB3L1/SHC1/H3C2,3
Organismal Systems,Nervous system,hsa04728,Dopaminergic synapse,2/278,69/2914,0.028985507246376812,0.30382650401418,-1.900294155098542,0.992311804072969,0.9999072451192372,0.9401637704623658,CREB3L1/DRD5,2
Organismal Systems,Nervous system,hsa04723,Retrograde endocannabinoid signaling,2/278,70/2914,0.02857142857142857,0.2994861253854059,-1.9262865966972733,0.9929719752605484,0.9999072451192372,0.9401637704623658,SLC17A6/GABRA6,2
Organismal Systems,Circulatory system,hsa04261,Adrenergic signaling in cardiomyocytes,2/278,74/2914,0.02702702702702703,0.28329768617538403,-2.027754779462734,0.9951018330278641,0.9999072451192372,0.9401637704623658,ATP2A3/CREB3L1,2
Human Diseases,Substance dependence,hsa05032,Morphine addiction,1/278,53/2914,0.018867924528301886,0.19777385638658884,-1.9137964922358397,0.9953202416665999,0.9999072451192372,0.9401637704623658,GABRA6,1
Human Diseases,Neurodegenerative disease,hsa05016,Huntington disease,3/278,96/2914,0.03125,0.32756294964028776,-2.1753878265834583,0.9963266513713265,0.9999072451192372,0.9401637704623658,ATP5F1D/CREB3L1/TUBB6,3
Organismal Systems,Endocrine system,hsa04921,Oxytocin signaling pathway,2/278,81/2914,0.024691358024691357,0.25881517008615323,-2.1966743624410627,0.9974138605600089,0.9999072451192372,0.9401637704623658,RGS2/CDKN1A,2
Organismal Systems,Nervous system,hsa04726,Serotonergic synapse,1/278,64/2914,0.015625,0.16378147482014388,-2.1963789802027436,0.9984829686010468,0.9999072451192372,0.9401637704623658,HTR1A,1
Environmental Information Processing,Signal transduction,hsa04371,Apelin signaling pathway,1/278,66/2914,0.015151515151515152,0.1588183998255941,-2.244459003059593,0.9987645354130911,0.9999072451192372,0.9401637704623658,SPHK2,1
Metabolism,Global and overview maps,hsa01100,Metabolic pathways,30/278,537/2914,0.055865921787709494,0.5855873960049838,-3.4524344767751955,0.9999072451192372,0.9999072451192372,0.9401637704623658,SPHK2/MTHFD2/DHRS9/ITPKC/ATP5F1D/PYGL/NME3/NAMPT/VNN2/CHAC1/CHSY1/HDC/GADL1/PTGES/PLOD2/LPCAT1/HK2/AMDHD2/PLD4/MVD/GPT/FUT1/OPLAH/HYAL3/CYP26C1/ACSL5/PNP/PDXP/ACY1/BCKDHA,30
